Covered recipient · General Payments record
ATIF GHAFFAR
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2021–2024
$3,404.98
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $746.41 | 26 |
| Education | $54.96 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $123.73 | 1 |
| ARGENX US, INC. | $115.42 | 1 |
| UCB, Inc. | $93.79 | 4 |
| Neurelis, Inc. | $84.66 | 5 |
| ABBVIE INC. | $77.40 | 2 |
| CSL Behring | $72.46 | 3 |
| Octapharma USA, Inc. | $70.36 | 2 |
| SK Life Science, Inc. | $61.63 | 3 |
| EMD Serono, Inc. | $37.90 | 2 |
| EISAI INC. | $33.75 | 2 |
| Biogen, Inc. | $30.27 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.44 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103791589 | CMS |
| ABBVIE INC. | $54.96 | 07/31/2024 | Education | Undisputed | 01/23/2026 | 1104195794 | CMS |
| Amgen Inc. | $123.73 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111582958 | CMS |
| ARGENX US, INC. | $115.42 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142112933 | CMS |
| Biogen, Inc. | $15.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104863972 | CMS |
| Biogen, Inc. | $15.27 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104806849 | CMS |
| CSL Behring | $28.66 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134645213 | CMS |
| CSL Behring | $18.29 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134645225 | CMS |
| CSL Behring | $25.51 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134645261 | CMS |
| Eisai Inc. | $13.97 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110732154 | CMS |
| Eisai Inc. | $19.78 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110732156 | CMS |
| EMD Serono, Inc. | $20.64 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120218014 | CMS |
| EMD Serono, Inc. | $17.26 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120263588 | CMS |
| Neurelis, Inc. | $20.05 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642040 | CMS |
| Neurelis, Inc. | $17.91 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642042 | CMS |
| Neurelis, Inc. | $14.05 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642044 | CMS |
| Neurelis, Inc. | $15.47 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642046 | CMS |
| Neurelis, Inc. | $17.18 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145642048 | CMS |
| Octapharma USA, Inc. | $47.13 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142314886 | CMS |
| Octapharma USA, Inc. | $23.23 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142314891 | CMS |
| SK Life Science, Inc. | $18.81 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139396 | CMS |
| SK Life Science, Inc. | $26.02 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139520 | CMS |
| SK Life Science, Inc. | $16.80 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154139522 | CMS |
| UCB, Inc. | $23.56 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015336 | CMS |
| UCB, Inc. | $20.32 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015338 | CMS |
| UCB, Inc. | $28.27 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015340 | CMS |
| UCB, Inc. | $21.64 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143015342 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.